Resource impact statement
No significant resource impact is anticipated
The NICE guideline on colorectal cancer: diagnosis and management updates and replaces the former guideline CG131 that published in 2011.
We do not expect this update to have a significant impact on resources; that is:
- the resource impact of implementing any single guideline recommendation in England will be less than £1 million per year (or £1,800 per 100,000 population) and
- the resource impact of implementing the whole guideline in England will be less than £5 million per year (or £9,000 per 100,000 population).
Where clinical practice changes as a result of this update to the previous NICE guideline, there will not be a significant change in resource use. This is because the overall incremental cost of treatment is low and any cost is likely to be offset by savings and benefits.
Colorectal cancer services are commissioned by NHS England and clinical commissioning groups. Providers are NHS hospital trusts.
This page was last updated: 29 January 2020